A team led by scientists from The Scripps Research Institute (TSRI) and the International AIDS Vaccine Initiative (IAVI) has unveiled a new technique for vaccine design that could be particularly useful against HIV and other ...
Mar 28, 2013
1
0
Our immune systems react most strongly to the viral strains we encountered in our childhoods. Scientists call this original antigenic sin (OAS)—the body's first blush with a virus like influenza or COVID being the "original ...
Jan 18, 2023
0
49
By now, many have become all too familiar with rapid antigen tests for diagnosis of COVID-19. Slightly less accurate than the genetic tests administered by healthcare professionals, the rapid antigen tests' ease-of-use allows ...
May 5, 2022
0
106
Interferon (IFN) responses are one of the first defenses the body mounts against viral infections, and research has shown that it plays a role controlling viral replication. But when researchers at Baylor College of Medicine ...
Sep 10, 2020
0
93
Viruses evolve over time, undergoing genetic changes, or mutations, in their quest to survive. Some viruses produce many variations, others only a few. Fortunately, SARS-CoV-2, the novel coronavirus that causes COVID-19, ...
Jun 10, 2020
0
1592
Antiretroviral therapy (ART) can suppress HIV to the point where the virus is nearly undetectable, and people on medication can live many years. But therapy cannot completely eradicate the virus; it persists in reservoirs ...
Oct 9, 2019
0
266
Genetic recombination between viral strains in bats may have produced the direct evolutionary ancestor of the strain that caused a deadly outbreak of severe acute respiratory syndrome (SARS) in humans, according to new research ...
Nov 30, 2017
0
22
Great strides have been made in recent years to develop treatment options for HIV, and the disease can now be controlled with anti-retroviral drugs. But a cure remains elusive and current medications have limitations: they ...
Jul 26, 2016
0
82
Scientists at Los Alamos National Laboratory have created a computational model that could change the way that researchers look at possibilities for an HIV-1 vaccine.
Sep 18, 2015
0
75
In the first results to emerge from HIV patient trials of a new generation of so-called broadly neutralizing antibodies, Rockefeller University researchers have found the experimental therapy can dramatically reduce the amount ...
Apr 8, 2015
0
38
